Literature DB >> 9828095

SV40-Mediated immortalization.

K K Jha1, S Banga, V Palejwala, H L Ozer.   

Abstract

Human diploid cells have a limited life span, ending in replicative senescence, in contrast to cell lines derived from tumors, which show an indefinite life span and are immortal, suggesting that replicative senescence is a tumor suppression mechanism. We have utilized introduction of SV40 sequences to develop matched sets of nonimmortal and immortal cell lines to help dissect the mechanism of immortalization and have found that it has multiple facets, involving both SV40-dependent and -independent aspects. These studies have led to the identification of a novel growth suppressor gene (SEN6) as well as providing a model system for the study of cellular aging, apoptosis, and telomere stabilization among other things. It is anticipated that SV40-transformed cells will continue to provide a very useful experimental system leading to insights into the behavior of cells with altered expression of oncogenes and growth suppressor gene products. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828095     DOI: 10.1006/excr.1998.4272

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  33 in total

1.  Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.

Authors:  M J O'Hare; J Bond; C Clarke; Y Takeuchi; A J Atherton; C Berry; J Moody; A R Silver; D C Davies; A E Alsop; A M Neville; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Simian virus 40 infection of humans.

Authors:  Robert L Garcea; Michael J Imperiale
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Conditional immortalization of primary adipocyte precursor cells.

Authors:  Christopher Church; Mallory Brown; Matthew S Rodeheffer
Journal:  Adipocyte       Date:  2015-01-20       Impact factor: 4.534

4.  Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen.

Authors:  E H Leung; P C Leung; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

5.  Novel isolation and biochemical characterization of immortalized fibroblasts for tissue engineering vocal fold lamina propria.

Authors:  Xia Chen; Susan L Thibeault
Journal:  Tissue Eng Part C Methods       Date:  2009-06       Impact factor: 3.056

6.  Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.

Authors:  Marieke A de Graaff; Jamie S E Yu; Hannah C Beird; Davis R Ingram; Theresa Nguyen; Jeffrey Juehui Liu; Svetlana Bolshakov; Károly Szuhai; Pierre Åman; Keila E Torres; Dina Lev; Torsten O Nielsen; Judith V M G Bovée; Alexander J Lazar; Neeta Somaiah
Journal:  Lab Invest       Date:  2016-06-06       Impact factor: 5.662

7.  Primary and immortalised human pancreatic islet endothelial cells: phenotypic and immunological characterisation.

Authors:  E Favaro; A Bottelli; B Lozanoska-Ochser; E Ferioli; G C Huang; N Klein; A Chiaravalli; P Cavallo Perin; G Camussi; M Peakman; P G Conaldi; M M Zanone
Journal:  Diabetologia       Date:  2005-11-15       Impact factor: 10.122

8.  Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.

Authors:  Laure Voisin; Marc K Saba-El-Leil; Catherine Julien; Christophe Frémin; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

9.  HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature.

Authors:  Stacey A Mattison; Gregory L Blatch; Adrienne L Edkins
Journal:  Cell Stress Chaperones       Date:  2016-12-16       Impact factor: 3.667

10.  Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes.

Authors:  Simon P Graham; Roger Pellé; Yoshikazu Honda; Duncan M Mwangi; Nyerhovwo J Tonukari; Mat Yamage; E Jane Glew; Etienne P de Villiers; Trushar Shah; Richard Bishop; Evelyne Abuya; Elias Awino; James Gachanja; Anthony E Luyai; Ferdinand Mbwika; Anthony M Muthiani; David M Ndegwa; Moses Njahira; John K Nyanjui; Fredrick O Onono; Julius Osaso; Rosemary M Saya; Claude Wildmann; Claire M Fraser; Ian Maudlin; Malcolm J Gardner; Subhash P Morzaria; Sheena Loosmore; Sarah C Gilbert; Jean-Christophe Audonnet; Pierre van der Bruggen; Vishvanath Nene; Evans L N Taracha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.